M&A Deal Summary

Novelion Therapeutics Acquires QLT USA

On June 14, 2004, Novelion Therapeutics acquired medical products company QLT USA for 855M USD

Acquisition Highlights

This is Novelion Therapeutics’ 1st transaction in the Medical Products sector.
This is Novelion Therapeutics’ largest (disclosed) transaction.
This is Novelion Therapeutics’ 1st transaction in the United States.
This is Novelion Therapeutics’ 1st transaction in Colorado.

M&A Deal Summary
Date	2004-06-14
Target	QLT USA
Sector	Medical Products
Buyer(s)	Novelion Therapeutics
Deal Type	Add-on Acquisition
Deal Value	855M USD

Target

QLT USA

Fort Collins, Colorado, United States

QLT USA, Inc. (Formerly Atrix Laboratories, Inc.) is an emerging specialty pharmaceutical company focused on advanced drug delivery. With unique patented sustained release and topical technologies, Atrix is currently developing a diverse portfolio of proprietary products, including oncology and dermatology products. The company also partners with large pharmaceutical and biotechnology companies to apply its proprietary technologies to new chemical entities or to extend the patent life of existing products.

Search 200,500 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer